The institutional landscape for Inhibrx Biosciences, Inc. (NASDAQ:INBX) includes 132 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 1,452,707 | 125,000 | 9.41% | $114,763,853.00 |
| VIKING GLOBAL INVESTORS LP | 31 Dec, 2025 | 1,437,705 | -350,000 | -19.58% | $113,578,695.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,167,728 | 724,872 | 163.68% | $92,250,538.00 |
| Sanofi | 31 Dec, 2025 | 1,157,926 | 0 | 0.00% | $91,476,154.00 |
| HighTower Advisors, LLC | 31 Dec, 2025 | 870,507 | -1,252 | -0.14% | $68,770,053.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 777,383 | 92,637 | 13.53% | $61,413,257.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 623,084 | 28,166 | 4.73% | $49,223,636.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 454,657 | 14,565 | 3.31% | $35,917,903.00 |
| Capital Research Global Investors | 31 Dec, 2025 | 421,575 | 421,575 | 0.00% | $33,304,425.00 |
| STATE STREET CORP | 31 Dec, 2025 | 374,961 | 171,038 | 83.87% | $29,621,919.00 |
| Caligan Partners LP | 31 Dec, 2025 | 323,565 | 87,182 | 36.88% | $25,561,635.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 297,116 | 297,116 | 0.00% | $23,472,164.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 275,917 | -21,903 | -7.35% | $21,797,443.00 |
| PFM Health Sciences, LP | 31 Dec, 2025 | 265,517 | 25,873 | 10.80% | $20,975,843.00 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 31 Dec, 2025 | 264,000 | 264,000 | 0.00% | $20,856,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 226,009 | 4,089 | 1.84% | $17,858,743.00 |
| Schonfeld Strategic Advisors LLC | 31 Dec, 2025 | 214,725 | 117,343 | 120.50% | $16,963,275.00 |
| DLD Asset Management, LP | 31 Dec, 2025 | 204,600 | 204,600 | 0.00% | $16,174,654.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 167,117 | 141,151 | 543.60% | $13,202,243.00 |
| Woodline Partners LP | 31 Dec, 2025 | 139,479 | -197,111 | -58.56% | $11,018,841.00 |